
Adaptimmune Therapeutics PLC
ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31
Reports and events: 279 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-05-1917:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-21-007554 |
| 2021-05-1408:39 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-066437 |
| 2021-05-0616:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-006230 |
| 2021-05-0607:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-006075 |
| 2021-04-0808:00 ET | DEF 14A | Proxy statementPeriod 2021-05-14 | 0001104659-21-047833 |
| 2021-02-2516:18 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001558370-21-001827 |
| 2021-02-2507:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-001720 |
| 2020-12-1617:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-20-136370 |
| 2020-11-2007:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-20-014003 |
| 2020-11-1909:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-20-013984 |
| 2020-11-0917:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-123143 |
| 2020-11-0516:18 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001558370-20-012867 |
| 2020-11-0507:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-121583 |
| 2020-10-1516:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-115322 |
| 2020-08-2810:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-099887 |
| 2020-08-0611:17 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001558370-20-009555 |
| 2020-08-0607:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-091131 |
| 2020-06-0216:49 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-069003 |
| 2020-05-2907:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-067350 |
| 2020-05-2907:07 ET | 8-K | 5.07 Shareholder vote results | 0001104659-20-067340 |
| 2020-05-2816:37 ET | 10-Q/A | Quarterly report, amendedPeriod 2020-03-31 | 0001104659-20-067101 |
| 2020-05-1411:02 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001558370-20-006569 |
| 2020-05-1407:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-061166 |
| 2020-05-1210:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-059925 |
| 2020-04-2908:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-052846 |
| 2020-04-2808:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-051986 |
| 2020-04-2008:00 ET | DEF 14A | Proxy statementPeriod 2020-05-29 | 0001104659-20-048476 |
| 2020-04-0808:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-20-044489 |
| 2020-02-2711:50 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001558370-20-001571 |
| 2020-02-2707:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-025722 |
| 2020-02-1808:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-022267 |
| 2020-02-0716:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-012543 |
| 2020-01-2217:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-005985 |
| 2020-01-1406:17 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-003597 |
| 2020-01-1308:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-003256 |
| 2020-01-1307:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-003216 |
| 2019-11-2616:30 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-19-067634 |
| 2019-11-0611:55 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001558370-19-010099 |
| 2019-11-0607:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-060267 |
| 2019-10-0108:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001410578-19-001480 |
| 2019-09-3008:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001410578-19-001463 |
| 2019-08-2708:39 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001410578-19-000929 |
| 2019-08-0111:59 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001558370-19-006758 |
| 2019-08-0107:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-19-043177 |
| 2019-08-0107:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-043176 |
| 2019-07-2508:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-041727 |
| 2019-07-2208:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-041172 |
| 2019-07-1808:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-040874 |
| 2019-06-2708:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-037761 |
| 2019-05-1508:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-029550 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.